# IGENICA BIOTHERAPEUTICS, INC — Form D/A

IGENICA BIOTHERAPEUTICS, INC of BURLINGAME, CA, a company, filed a Form D amendment with the SEC on 2011-09-28. The offering totals $24.1M, of which $16.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-09-28
- Form: D/A
- Accession: 0001453044-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $24.1M
- Amount sold: $16.1M
- Remaining: $8.0M
- Investors: 6
- Date of first sale: 2010-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-141481

## Issuer

- Name: IGENICA BIOTHERAPEUTICS, INC
- CIK: 0001453044
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 863A MITTEN RD., BURLINGAME, CA, 94040
- Phone: (650) 231-4320

## Officers, directors & promoters (17)

| Name | Role | Location |
| --- | --- | --- |
| Mike Rothe | Director | Burlingame, CA |
| Mike Rothe | Executive Officer | Burlingame, CA |
| CARL GORDON | Director | SAN DIEGO, CA |
| David Goeddel | Director | Agoura Hills, CA |
| David Goeddel | Executive Officer | Agoura Hills, CA |
| Mary Haak-Frendscho | Director | Hayward, CA |
| Mary Haak-Frendscho | Executive Officer | Hayward, CA |
| Mark A Goldsmith | Director | Redwood City, CA |
| John Celebi | Executive Officer | Cambrdge, MA |
| John Diekman | Director | Menlo Park, CA |
| Mark Goldsmith | Director | Burlingame, CA |
| Robert Schreiber | Director | Burlingame, CA |
| Gwen Fyfe | Director | Burlingame, CA |
| John A Celebi | Executive Officer | Burlingame, CA |
| Gwen A Fyfe | Director | Burlingame, CA |
| Guoqing Chen | Executive Officer | Burlingame, CA |
| Luis Bayol | Executive Officer | South San Francisco, CA |

## Other filings by this issuer (11)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-10-14](https://search.stillhousedata.com/formd/0001453044-15-000006) | D | $5.0M | $2.3M |
| [2015-06-09](https://search.stillhousedata.com/formd/0001453044-15-000004) | D | $4.0M | $1.2M |
| [2015-01-26](https://search.stillhousedata.com/formd/0001453044-15-000003) | D | $6.3M | $5.1M |
| [2014-02-07](https://search.stillhousedata.com/formd/0001453044-14-000001) | D | $14.1M | $7.0M |
| [2012-12-04](https://search.stillhousedata.com/formd/0001453044-12-000004) | D/A | $33.3M | $20.3M |
| [2012-10-11](https://search.stillhousedata.com/formd/0001453044-12-000003) | D | $17K | — |
| [2012-06-22](https://search.stillhousedata.com/formd/0001453044-12-000002) | D | $33.1M | $10.0M |
| [2012-05-02](https://search.stillhousedata.com/formd/0001453044-12-000001) | D | $42K | — |
| [2010-09-09](https://search.stillhousedata.com/formd/0001453044-10-000003) | D | $72K | — |
| [2010-05-04](https://search.stillhousedata.com/formd/0001453044-10-000001) | D | $24.1M | $8.0M |
| [2009-07-17](https://search.stillhousedata.com/formd/0001453044-09-000004) | D | $23K | — |

## More

- [CIK 1453044 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1453044&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001453044-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.